# Corteva, Inc. (CTVA) · Edgar & Edgarette company card

> Corteva (CTVA) grew revenue 2.9% in FY2025 to $17.4 billion, equity 56.4% of assets, and dividend per share up 4 years running. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1755672 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/CTVA) · [JSON](https://www.pops4.com/boards/company/CTVA.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $17.4B |
| Revenue growth, 1 year | 2.9% |
| Revenue growth per year | 2.7% |
| Operating margin | — |
| Net margin | 6.4% |
| Operating cash flow | $3.4B |
| Capital spending | $591M |
| Free cash flow | $2.8B |
| Cash | $4.5B |
| Long-term debt | $1.7B |
| Total assets | $42.8B |
| Total equity | $24.1B |
| Equity ÷ assets | 56.4% |
| Return on equity | 4.6% |
| Dividend per share | $0.7 |
| Dividend years rising | 4 |

## Readings, computed from those figures

- Piotroski F: 7 of 9 (solid)
- Beneish M: -2.74 (below the −1.78 line)
- Health Harbor boat: New ship · no warning signs
- Cash Compass: Cash cow now · steady, with strong cash arriving today

## Edgarette's reading

Exposure: revenue $17.4B (FY2025), total debt $1.7B. Experience: revenue up 2.9% on the year, up 2.7% a year over 4 years. Soundness: equity 56.4% of assets, return on equity 4.6%, payout 43.0% of profit, dividend per share up 4 years running. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $15.7B and $18.6B next year (method v4.1: its own 4-year record of growth weighed at 50% against $10B+ filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $14.5B to $19.9B. A statistical range, not company guidance. Against peers (10 filers, $50M+ revenue, agricultural production-crops): growth 2.9% against -0.9%.

Range logged 2026-09-26, receipt b2ddb9ef058f7fa3, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 3, latest 2026-10-07 ([filing](https://www.sec.gov/Archives/edgar/data/1755672/000119312526417064/0001193125-26-417064-index.htm))

## Recent filings

- 8-K · filed 2026-10-13 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1755672/000119312526419637/0001193125-26-419637-index.htm)
- 8-K · filed 2026-10-07 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/1755672/000119312526417064/0001193125-26-417064-index.htm)
- 8-K · filed 2026-10-07 · 3.03 Material Modifications to Rights of Security Holders; 8.01 Other Events; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1755672/000119312526417062/0001193125-26-417062-index.htm)
- 8-K · filed 2026-10-05 · 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1755672/000119312526414490/0001193125-26-414490-index.htm)
- 8-K · filed 2026-10-01 · 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1755672/000175567226000028/0001755672-26-000028-index.htm)
- 8-K · filed 2026-10-01 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1755672/000119312526409895/0001193125-26-409895-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001755672.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1755672

## Cite

POPS4, Edgar & Edgarette: Corteva, Inc. (CTVA) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/CTVA. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.